To hear about similar clinical trials, please enter your email below
Trial Title:
Danish Breast Cancer Group Internal Mammary Node Study
NCT ID:
NCT06549920
Condition:
Breast Cancer
Conditions: Official terms:
Breast Neoplasms
Conditions: Keywords:
Internal mammary node irradiation
Node-positive breast cancer
Study type:
Interventional
Study phase:
N/A
Overall status:
Active, not recruiting
Study design:
Allocation:
Non-Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Treatment
Masking:
None (Open Label)
Intervention:
Intervention type:
Radiation
Intervention name:
Internal mammary node irradiation
Description:
Irradiation of the internal mammary nodes in intercostal space 1-4.
Arm group label:
Internal mammary node irradiation
Other name:
IMNI
Summary:
The DBCG IMN study is a nationwide prospective population-based cohort study allocating
node-positive breast cancer patients with right-sided tumors to internal mammary node
irradiation (IMNI) and patients with left-sided tumors to no IMNI.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Patients with macrometastatic node-positive breast cancer treated with loco-regional
radiotherapy.
Exclusion Criteria:
- Prior malignancies, bilateral breast cancer, neoadjuvant systemic therapy,
recurrence before radiotherapy, and non-standard radiotherapy.
Gender:
All
Minimum age:
N/A
Maximum age:
N/A
Healthy volunteers:
No
Start date:
January 1, 2003
Completion date:
January 1, 2034
Lead sponsor:
Agency:
Danish Breast Cancer Cooperative Group
Agency class:
Other
Source:
Danish Breast Cancer Cooperative Group
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06549920
